Grupo para la caracterización molecular de las neoplasias hematológicas
Universidade de São Paulo
São Paulo, BrasilPublicaciones en colaboración con investigadores/as de Universidade de São Paulo (3)
2021
-
Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial
The Lancet, Vol. 397, Núm. 10292, pp. 2361-2371
2016
-
Development and evaluation of a secondary reference panel for BCR-ABL1 quantification on the International Scale
Leukemia, Vol. 30, Núm. 9, pp. 1844-1852
2015
-
All-trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic leukaemia: A matched-pair analysis of the PETHEMA LPA-2005 and IC-APL studies
Annals of Hematology, Vol. 94, Núm. 8, pp. 1347-1356